News

The immunotherapy OST-HER2 combined with palliative radiation has shown positive data in preventing or delaying amputation ...
Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...
While children’s appetites can fluctuate, a rapid, unexplained drop in weight or consistent refusal to eat warrants a professional assessment. Lymphoma or other malignancies may manifest through ...
Arcie Lovato and Anna Reed were both diagnosed with osteosarcoma and met at HCA HealthONE Rocky Mountain Children’s, where ...
Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor ...
“We are excited to partner with Lisata to investigate how certepetide and the SMARTag ® technology might be used together to make ADCs with enhanced functions,” stated Penelope Drake, Head of R&D, ...
Canadian actor Ryan Reynolds is lending his voice to a heartfelt cause and urging the town of Cobourg, Ont., to rename a ...
OST-HER2 has received Rare Pediatric Disease Designation (RPDD) for osteosarcoma from the US FDA, and if it receives a conditional BLA via Accelerated Review prior to September 30, 2026 ...
(RTTNews) - OS Therapies Inc. (OSTX) Thursday announced positive data for OST-HER2 in combination with palliative radiation in dogs with unresected appendicular osteosarcoma. Results from the ...
OST-HER2 is an immunotherapy for osteosarcoma using a HER2 bioengineered form of the bacteria Listeria monocytogenes to trigger a strong immune response against cancer cells expressing HER2.